Aspen Aerogels Posts $10.4 Million Third-Quarter Loss

The Northborough, Massachusetts-based company reported third-quarter revenue of $85.2 million and projected fourth-quarter revenue between $60 million and $75 million.

Updated on Nov. 5, 2026 in Public Companies

Aspen Aerogels Posts $10.4 Million Third-Quarter Loss

Aspen Aerogels reported a third-quarter loss of $10.4 million, or 13 cents per share, compared with an analyst average estimate of a loss of 9 cents per share. Adjusted earnings came to 11 cents per share on revenue of $85.2 million.

Why it matters

The results came in below analyst expectations on both the bottom line and the top line, with the company's own fourth-quarter revenue outlook also giving investors a range to weigh. The company's shares closed at $4.80, down from $7.19 a year earlier.

Aspen Aerogels posted third-quarter revenue of $85.2 million against an analyst estimate of $72.3 million, while adjusted earnings of 11 cents per share reversed the reported loss of 13 cents. The reconciliation between reported and adjusted figures was not detailed in the available data.

The players

Aspen Aerogels

Aspen Aerogels is a Northborough, Massachusetts-based maker of aerogel insulation and energy-efficiency materials that trades as a publicly listed company.

The details

Aspen Aerogels reported its third-quarter results on Thursday, November 5, 2026, showing a net loss of $10.4 million on revenue that beat Zacks analyst estimates. The company also projected fourth-quarter revenue of $60 million to $75 million for the quarter ending in December.

Third quarter 2026: Aspen Aerogels reports $10.4 million loss and $85.2 million revenue.
Thursday, November 5, 2026: Earnings report released.
Quarter ending December 2026: Company projects revenue of $60 million to $75 million.

Market Landscape

Aspen Aerogels' third-quarter results were measured against the Zacks consensus of four analysts, which expected a loss of 9 cents per share and revenue of $72.3 million. The company's revenue beat that consensus even as its per-share loss widened beyond it.

Investors holding Aspen Aerogels shares are weighing a share price of $4.80 against a year-earlier price of $7.19 and a fourth-quarter revenue outlook of $60 million to $75 million. Revenue guidance is the figure most likely to shape near-term decisions, since it frames the company's expected business volume.

The takeaway

Aspen Aerogels beat revenue estimates while widening its per-share loss, and its fourth-quarter guidance gives investors a range to track. Reviewing the reconciliation between reported and adjusted earnings in the company's filings will clarify how the two figures differ.